Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis

NCT03471611 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis, Coronary

Interventions

DRUG: Autologous CD34+ Cells
DRUG: Granulocyte Colony-Stimulating Factor (G-CSF)

Sponsor

Mayo Clinic